The number of Ebola infections in Central Africa is growing, as Spiegel reports. International donors are now providing millions for vaccine development. A large portion of the funds goes to US manufacturer Moderna.
The financial aid is intended to support companies and researchers in the fight against the deadly disease. Moderna receives a significant share of the funds to advance its vaccine candidates. The exact amounts and distribution to other recipients were not disclosed.
Source: www.spiegel.de
